RJSBio, Inc.

RJSBio is developing “tethered addressed” non-peptide small-molecules for the treatment of cancer and inflammatory conditions.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Seattle, WA, US
  • Currency USD
  • Founded February 2009
  • Employees 8
  • Website rjsbiologics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free